Back to Stocks

Laurus Labs Limited

LAURUSLABSNSEHealthcare

Laurus Labs Limited
981.60 3.88%(+36.70)

Previous Close

944.90

Last Updated

20 Mar, 07:18 am

Market Cap

N/A

P/E Ratio

62.963436

52W High

1,141.00

52W Low

517.65

Open

₹975.00

High

₹975.20

Low

₹936.30

Volume

8,28,211

Price Chart with Technical Indicators

• Blue line: Stock price

• Yellow dashed line: 20-day moving average

• Red dashed line: 50-day moving average

• Gray line: Trading volume (scaled for visualization)

Performance Analysis

52W Range Position

74.4%

Above midpoint

From 52W High

14.0%

From 52W Low

+89.6%

Average Price

₹944.90

Trading Metrics

Volume

8,28,211

Avg Volume

13,29,260

Volume Ratio

0.62x

Normal

Volatility

N/A

Moderate

Financial Fundamentals

Profit

0.00 Cr

Debt

0.00 Cr

Risk Assessment

Overall Risk LevelLow

Price Stability

Volatile

Market Position

Strong

Liquidity

Moderate

Valuation Metrics

P/E Ratio

62.963436

Overvalued

About Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Latest News

No news available for this stock.